Editorial comment
- PMID: 20451726
- DOI: 10.1016/j.urology.2009.07.1290
Editorial comment
Comment on
-
The loss of radiographic enhancement in primary renal cell carcinoma tumors following multitargeted receptor tyrosine kinase therapy is an additional indicator of response.Urology. 2010 May;75(5):1108-13.e1. doi: 10.1016/j.urology.2009.06.105. Epub 2009 Nov 20. Urology. 2010. PMID: 19931124